These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

569 related items for PubMed ID: 19080277

  • 21. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI, Lin HC, Hsia CY, Huang YH, Wu JC, Chiang JH, Chiou YY, Lui WY, Lee PC, Lee SD.
    Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Comparison of the model for end-stage liver disease (MELD), MELD-Na and MELDNa for outcome prediction in patients with acute decompensated hepatitis.
    Hsu CY, Lin HC, Huang YH, Su CW, Lee FY, Huo TI, Lee PC, Lee JY, Lee SD.
    Dig Liver Dis; 2010 Feb; 42(2):137-42. PubMed ID: 19595648
    [Abstract] [Full Text] [Related]

  • 26. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW, Huo TI, Yang YY, Hou MC, Lee PC, Lin HC, Lee FY, Chi CW, Lee SD.
    J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
    [Abstract] [Full Text] [Related]

  • 27. Serum sodium predicts mortality in patients listed for liver transplantation.
    Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA.
    Hepatology; 2005 Jan; 41(1):32-9. PubMed ID: 15690479
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E, Botta F, Fumagalli A, Malfatti F, Testa E, Chiarbonello B, Polegato S, Bellotti M, Milazzo S, Borgonovo G, Testa R.
    Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
    [Abstract] [Full Text] [Related]

  • 30. Model for end-stage liver disease (MELD) and allocation of donor livers.
    Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, Wolfe RA, Krom R, United Network for Organ Sharing Liver Disease Severity Score Committee.
    Gastroenterology; 2003 Jan; 124(1):91-6. PubMed ID: 12512033
    [Abstract] [Full Text] [Related]

  • 31. [Application of Model for end-stage liver disease to predict the prognosis of and curative effect for chronic severe hepatitis].
    Liu Q, Liu Z, Wang TL, Zhang LL.
    Zhonghua Yi Xue Za Zhi; 2005 Jul 06; 85(25):1773-7. PubMed ID: 16253168
    [Abstract] [Full Text] [Related]

  • 32. Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systems.
    Huo TI, Hsia CY, Huang YH, Lin HC, Lee PC, Lui WY, Chiang JH, Chiou YY, Loong CC, Lee SD.
    J Clin Gastroenterol; 2009 Sep 06; 43(8):773-81. PubMed ID: 19262404
    [Abstract] [Full Text] [Related]

  • 33. The MELD scoring system for predicting prognosis in patients with severe hepatitis after plasma exchange treatment.
    Yu JW, Wang GQ, Zhao YH, Sun LJ, Wang SQ, Li SC.
    Hepatobiliary Pancreat Dis Int; 2007 Oct 06; 6(5):492-6. PubMed ID: 17897912
    [Abstract] [Full Text] [Related]

  • 34. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
    Radha Krishna Y, Saraswat VA, Das K, Himanshu G, Yachha SK, Aggarwal R, Choudhuri G.
    Liver Int; 2009 Mar 06; 29(3):392-8. PubMed ID: 19267864
    [Abstract] [Full Text] [Related]

  • 35. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
    Angermayr B, Luca A, König F, Bertolini G, Ploner M, Gridelli B, Ulbrich G, Reiberger T, Bosch J, Peck-Radosavljevic M.
    Eur J Clin Invest; 2009 Jan 06; 39(1):65-71. PubMed ID: 19087131
    [Abstract] [Full Text] [Related]

  • 36. Assessment of short-term survival after liver transplant by the Model for End-Stage Liver Disease.
    Buenadicha AL, Martín LG, Martín EE, Pajares Ad, Pérez AM, Seral CC, Marugán RB.
    Transplant Proc; 2005 Nov 06; 37(9):3881-3. PubMed ID: 16386571
    [Abstract] [Full Text] [Related]

  • 37. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O, Perrella A, Arenga G.
    Transplant Proc; 2008 Nov 06; 40(6):1906-9. PubMed ID: 18675085
    [Abstract] [Full Text] [Related]

  • 38. [Serum sodium concentration profile for cirrhotic patients and its effect on the prognostic value of the MELD score].
    Zhang JY, Qin CY, Jia JD, Wang BE.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Feb 06; 20(2):108-11. PubMed ID: 22464781
    [Abstract] [Full Text] [Related]

  • 39. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
    Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, Fisher RA, Mihas AA.
    Hepatology; 2004 Oct 06; 40(4):802-10. PubMed ID: 15382176
    [Abstract] [Full Text] [Related]

  • 40. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
    Fejfar T, Safka V, Hůlek P, Vanásek T, Krajina A, Jirkovský V.
    Vnitr Lek; 2006 Sep 06; 52(9):771-6. PubMed ID: 17091599
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.